#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Immunodeficiency common variable Transitional cell cancer of the renal pelvis and ureter VEXAS syndrome Hereditary angioedema with C1 esterase inhibitor deficiency IPEX syndrome Mantle cell lymphoma Anal squamous cell carcinoma Malignant peritoneal neoplasm Pleural mesothelioma malignant Cytomegalovirus infection Marfan's syndrome Hypoxic-ischaemic encephalopathy Cholestatic pruritus Prostate cancer Thrombotic thrombocytopenic purpura More trials…

    Learn about Rare Diseases

    Hereditary angioedema – Diagnostics Fragile X syndrome – Diagnostics Epidermolysis bullosa – Life with Disease Congenital nephrogenic diabetes insipidus – Treatment Crigler-Najjar syndrome – Diagnostics Erdheim-Chester disease – Trials in Disease Osteosarcoma recurrent – Diagnostics Rosai-Dorfman syndrome Brain stem glioma – Life with Disease Methylmalonic acidaemia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lutetium (177Lu) Oxodotreotide Rezpegaldesleukin NVG-2089 Isosorbide Dinitrate GSKVX000000046019 ULVIPRUBART Oxycodone Hydrochloride Testosterone Undecanoate Eltrombopag Palivizumab CICLOPIROX Eplerenone Datopotamab Deruxtecan Oxaliplatin 18F-Psma-1007 Tazemetostat Linezolid Golexanolone Fipaxalparant Histidine More therapies…

    Learn about Your Condition

    Meniscus operation Pulmonary hypertension Sexual dysfunction Skin candida Hypersomnia Ovarian cancer recurrent Ehlers-Danlos syndrome Diphtheria Rheumatoid arthritis Anal cancer recurrent Mumps Familial mediterranean fever Burkitt's lymphoma Sarcoidosis Bone hypertrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Chronic kidney disease

  • Study on the Effects of Dapagliflozin on Kidney Health in Patients with Chronic Kidney Disease After Kidney Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Dapagliflozin
    Germany

  • Study on Patiromer for Improving RAAS Treatment in Patients with Chronic Kidney Disease Stages 3b/4

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Hydrochlorothiazide
    • Irbesartan
    The Netherlands

  • Study on Dapagliflozin for Patients with Severe Chronic Kidney Disease to Improve Kidney and Heart Health Outcomes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Chronic kidney disease
    Investigated Drugs:
    • Dapagliflozin
    Belgium Germany The Netherlands Spain

  • Study on How Tacrolimus Monohydrate and Mycophenolate Mofetil Affect Gut Bacteria in Patients with Chronic Kidney Disease After Transplant

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    • Chronic kidney disease
    Investigated Drugs:
    • Tacrolimus Monohydrate
    • Mycophenolate Mofetil
    Belgium

  • Study Comparing Cytisinicline and Nicotine Therapy for Patients with Nicotine Dependence and Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Nicotine dependence
    • Chronic kidney disease
    Investigated Drugs:
    • Cytisinicline
    • Nicotine
    Poland

  • Study on the Long-Term Safety of Finerenone with ACE Inhibitors or ARBs for Children and Young Adults with Chronic Kidney Disease and Proteinuria

    Recruiting

    3 1 1
    Investigated Diseases:
    • Proteinuria
    • Chronic kidney disease
    Investigated Drugs:
    • Finerenone
    Austria Belgium Bulgaria Czechia Denmark Finland +11
Previous Page
1 2 3 4 5 6 … 11
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!